Sign in
4

Changes in Ownership

ArriVent BioPharma, Inc. Filed Acc 0001104659-26-076566

Options or other derivatives

  • Director acquired 13,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nolet Chris Director 2026-06-18 Grant or award · Non-Qualified Stock Option (right to buy) +13,562 13,562 D: show line 1 in the form
Loading xslF345X06/tm2618519-1_4seq1.xml…